Recall of several batches of Combiwave 250,25 µg/ Pressurised inhalation product
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Combiwave 250,25 µg/ Pressurised inhalation Fluticasone Propionate, Salmeterol 1202256882 12250193B 12250232A 12250233A 12250332A 12250339A 12240471 12240771 12240772 12241372A Glenmark...
التصنيف
ملف
التاريخ
2025-10-20
اسم المستحضر
Combiwave 250,25 µg
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
The Saudi Food and Drug Authority (SFDA) has issued a recall of several batches of the product Combiwave 250,25 µg/ Pressurised inhalation due to the batches’ non-compliance with the approved specifications of the product.
التوصيات
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。